UI Investissement, formerly known as UI Gestion SAS, is a private equity and venture capital firm established in 2004 and headquartered in Paris, France. The firm specializes in investments in small to mid-cap companies across various sectors, with a particular focus on healthcare, agri-food, and services industries. Over the years, UI Investissement has actively supported the growth of more than 120 small and medium-sized enterprises, investing over €550 million in their development projects. The firm aims to finance a wide range of business stages, including seed, startup, and growth capital, as well as buyouts and turnaround transactions. Its investment strategy is regionally focused, primarily targeting areas in France such as Aquitaine, Brittany, and Ile-de-France, and it typically invests between €1 million and €50 million depending on the enterprise value of the companies. UI Investissement aims to act as both a majority and minority shareholder, leveraging its experience and corporate culture to foster sustainable performance in its portfolio companies.
Fizimed SAS, founded in 2017 and based in Strasbourg, France, specializes in manufacturing a perineal device designed to address urinary incontinence in women through pelvic floor reeducation. The company's flagship product, EMY, is a perineal probe that connects to a mobile app, allowing users to engage in personalized exercises for strengthening pelvic floor muscles. EMY not only captures real-time muscle contractions but also incorporates interactive elements, such as games, to motivate users during their five-minute workouts. Fizimed emphasizes user-friendliness and safety in its product design, aiming to empower women in managing their pelvic health at home. Additionally, the company actively seeks to eliminate the stigma surrounding urinary incontinence, fostering a supportive community on social media where women can share experiences and innovations related to this common health issue. Through its combination of medical efficacy and engaging technology, Fizimed aims to provide women with the tools they need to regain control over their pelvic health in a discreet and enjoyable manner.
Quibim
Series A in 2025
Quibim, headquartered in Valencia, Spain, is a leader in whole-body medical imaging analysis, providing innovative AI-based image processing technologies. Its products, utilized by pharmaceutical companies and research teams globally, focus on extracting quantitative information from radiological images. Quibim Precision®, the company's whole-body imaging ecosystem, supports a variety of applications, from disease detection to monitoring the effectiveness of new treatments. By employing an AI-first approach, Quibim enables partners to accurately identify pathologies across different body parts and imaging modalities, ultimately enhancing the diagnosis of high-incidence illnesses and assessing treatment outcomes. This commitment to leveraging advanced imaging biomarkers contributes significantly to improving human health.
Laclarée
Seed Round in 2025
Laclarée Vision specializes in the development of adaptive eyeglasses designed to correct presbyopia. Founded in 2016 and based in Lyon, France, the company utilizes patented fluid technology to create lenses that automatically adjust in real-time to various viewing distances. This innovative approach addresses the needs of individuals aged 45 and older who often find traditional solutions, such as progressive lenses or multiple pairs of glasses, unsatisfactory. By combining adaptive lens technology with refractive correction for conditions like astigmatism, myopia, and hyperopia, Laclarée aims to provide a clearer vision experience for its users.
AdEchoTech
Venture Round in 2024
AdEchoTech is a French company based near Paris, founded in 2008 by Dr. Éric Lefebvre, an experienced ultrasound radiologist. The company focuses on developing remote ultrasonography devices to address medical desertification and the shortage of healthcare services in underserved areas. AdEchoTech specializes in the design, manufacture, and marketing of robotic ultrasound equipment for various medical applications, including abdominal, cardiac, pelvic, urinary tract, and gynecologic care. By incorporating input from the medical community during the design process, AdEchoTech ensures that its solutions effectively meet the needs of healthcare providers and improve patient care. The company's innovations aim to reduce transportation costs and enhance the availability of sonographers, ultimately contributing to better public health outcomes.
SurgAR
Venture Round in 2024
SurgAR specializes in augmented reality software tailored for computer-aided laparoscopic surgery. Its innovative solution offers a plug-and-play system that enhances minimally invasive surgical procedures. The software is designed to automatically detect tumors that require resection and highlights critical anatomical structures, thereby assisting surgeons in navigating complex surgical environments more effectively. By streamlining the surgical process, SurgAR aims to improve surgical outcomes and enhance the overall efficiency of laparoscopic procedures.
Brightflow
Series A in 2024
Brightflow operates as a medical device startup.
Pixee Medical
Series B in 2024
Pixee Medical is a medical technology company based in Chavanod, France, founded in 2017. The company specializes in the manufacturing of computer-assisted surgical solutions that utilize advanced computer vision and artificial intelligence technologies. Pixee Medical produces medical equipment designed to control the positioning of implants during orthopedic surgeries. Its innovative tracking tools enable precise three-dimensional localization of surgical objects, allowing healthcare professionals to perform procedures with millimeter accuracy. By focusing on affordability, Pixee Medical aims to provide effective surgical navigation solutions that address the challenges of the current healthcare environment.
Vulkam
Venture Round in 2023
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, that specializes in the design, development, and production of amorphous metal parts. Founded in 2017, Vulkam utilizes biocompatible amorphous metal alloys primarily composed of materials such as zirconium, copper, hafnium, nickel, and titanium. The company's innovative products find applications across various industries, including aerospace, automotive, biomedical, cryogenic, watches, jewellery, and micro components. Vulkam's focus on creating micromechanical parts that are significantly smaller yet maintain strength and functionality sets a new standard in metallurgy and metal processing, positioning the company as a leader in the development of advanced metal technologies.
Sunrise
Series A in 2023
Sunrise focuses on addressing the widespread issue of sleep disorders, particularly sleep apnea, which affects nearly one billion people globally. The company has developed a 3-gram sensor that provides a rapid, at-home diagnosis of sleep apnea, utilizing trigeminal drive analysis to detect respiratory events. This certified medical device connects seamlessly to a smartphone, allowing for easy use and immediate results. Clinical studies have demonstrated that Sunrise's technology matches the accuracy of traditional in-lab sleep studies but at a significantly lower cost. After testing, patients can consult with certified sleep doctors online or visit local sleep centers, streamlining the diagnostic process. With a large percentage of sleep apnea cases remaining undiagnosed, Sunrise offers a crucial solution for patients, caregivers, and insurers, enhancing the accessibility and efficiency of sleep disorder diagnostics.
Neurinnov
Seed Round in 2021
Neurinnov specializes in the development and manufacturing of advanced neurostimulation solutions aimed at enhancing the quality of life for patients with spinal cord injuries. The company focuses on creating active implantable medical devices designed specifically for quadriplegic individuals, allowing them to regain essential hand grasping functions and increased autonomy. By employing sophisticated neurostimulation technology, Neurinnov's devices selectively activate specific muscle groups through targeted electrical stimulation of nerve fibers, thereby minimizing undesired side effects. This innovative approach offers a promising therapeutic avenue for individuals with paralysis, helping them restore vital motor functions.
Helpevia
Venture Round in 2021
Helpevia is a company that assists private health establishments in optimizing their purchasing processes. It provides a range of services, including consulting, technical assistance, and support for medical and pharmaceutical needs. Helpevia specializes in medical devices and coordinates tenders while negotiating referral contracts to enhance purchasing efficiency. Additionally, the company offers advice on surgical procedures, medications, biomedical maintenance, and medical supplies. By streamlining procurement and facilitating access to necessary resources, Helpevia aims to improve the operational performance of healthcare providers.
Lewis Industries
Private Equity Round in 2015
Lewis Industries specializes in the design and manufacture of precision sheet metal parts, incorporating electronic components as necessary to deliver fully assembled equipment. Founded in 1966 and based in Nemours, France, the company serves various sectors including medical, lighting, information technology, telecommunications, heating, transport, and instrumentation. With over 40 years of experience, Lewis Industries is known for its expertise in high precision operations such as laser cutting, sheet metal bending, welding, assembly, and finishing. The company is committed to providing parts with both simple and complex geometries, as well as functional units tailored to the specific needs of its clients.
Didactic
Private Equity Round in 2007
Didactic specializes in the manufacture and distribution of sterile and non-sterile medical devices, aimed at enhancing the safety and efficiency of healthcare professionals. The company provides solutions for both public and private healthcare sectors in France, focusing on five key product lines: protection, perfusion, injection, urology, and care. Their offerings include a range of medical supplies such as perfusion and transfusion equipment, tube extensions, examination gloves, and urine collectors. By prioritizing the needs of caregivers, Didactic aims to improve patient well-being through its innovative mouth care, hand protection, and sterilization solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.